Beneficial effects of L-arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster

Cell and Tissue Research

Volumn 308, Issue 1, 2002, Pages 109-120

  Popov, Doina ^a   Costache, Gabriela ^a   Georgescu, Adriana ^a   Enache, Mirela ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Glomerular capillaries; Heart capillaries; Resistance arteries; Simultaneous hyperlipemia diabetes; Syrian hamster; Vascular tonus

Indexed keywords

ACETYLCHOLINE; ARGININE; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY RESISTANCE; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CELL ULTRASTRUCTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFECT; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; EXTRACELLULAR MATRIX; GLOMERULUS; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HEART VENTRICLE WALL; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY BLOOD VESSEL; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; OSMOTIC FRAGILITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SPECTROPHOTOMETRY; SUPPLEMENTATION; SYRIAN HAMSTER;

ANIMALIA; CRICETINAE; GLOMERULUS; MESOCRICETUS AURATUS;

EID: 0036257416     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-001-0509-4     Document Type: Article

References (64)

1. Effect of long-term treatment with D-NALE and L-NAME with and without L-arginine on cardiovascular system in rats
2. A reliable marker of endothelial cell dysfunction: Does it exist?
3. L-Arginine reduces heart rate and improves hemodynamics in severe congestive heart failure
4. The clinical pharmacology of L-arginine
5. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production
6. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease
7. Regression or progression. Dependency on nitric oxide
8. Can L-arginine improve myocardial protection during cardioplegic arrest? Results of a phase I pilot study
9. L-Arginine in the management of cardiovascular diseases
10. Comparative study of elgodipine and nisoldipine on the contractile responses of various isolated blood vessels
11. Endothelial cells in physiology and in the pathophysiology of vascular disordes
12. Antiatherosclerotic effects of L-arginine in hypercholesterolemic rabbit
13. The effects of simultaneous hyperlipemia-hyperglycemia on the mesenteric resistance arteries, myocardium and kidney glomeruli
14. High glucose induces ventricular instability and increases vasomotor tonr in rats
15. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats
16. The effect of antioxidant vitamins E and C on lipoperoxidation of erythrocyte membranes during hyperbaric oxygenation
17. Effect of L-arginine on myocardial thallium-201 perfusion during exercise in patient with angina perctoris and normal coronary angiograms
18. Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine
19. Correction of endothelial dysfunction in chronic heart failure: Additional effects of exercise training and oral L-arginine supplementation
20. The endothelium: Dysfunction and beyond
21. Limitations of exogenous L-arginine in exerting a cytoprotective effect on hepatic ischemia/reperfusion injury
22. Link between glycation and lipoperoxidation in red blood cells in diabetes
23. Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients
24. Formation of 9-hydroxy linoleic acid as a product of phospholipid peroxidation in diabetic erythrocyte membranes
25. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells
26. L-Arginine and S-nitrosoglutathione reduce embolization in humans
27. Can L-arginine manipulation reduce renal disease?
28. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants
29. Supplementation with vitamin C, vitamin E or beta-carotene influences osmotic fragility and oxidative damage of erythrocytes of zinc-deficient rats
30. L-Arginine reduces lipid peroxidation in patients with diabetes mellitus
31. Regulation of hyperglycemia and dyslipidemia by exogenous L-arginine in diabetic rats
32. Effect of L-arginine-nitric oxide system on the metabolism of essential fatty acids in chemical-induced diabetes mellitus
33. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats
34. Protective effect of L-arginine against stress-induced gastric mucosal lesions in rats and its relation to nitric oxide-mediated inhibition of neutrophil infiltration
35. Diminished reserve for cerebral vasomotor response to L-arginine in the elderly: Evaluation by transcranial Doppler sonography
36. The effects of chronic L-arginine treatment on vascular responsiveness of streptozotocin-diabetic rats
37. Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat
38. From rats to man: A perspective on dietary L-arginine supplementation in human renal disease
39. Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine in endothelial dysfunction
40. Short-term oral administration of L-arginine reverses defective endothelium-dependent relaxation and cGMP generation in diabetes
41. Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat
42. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction
43. Links between hypertension and myocardial infarction
44. The role of endothelium in cardiovascular homeostasis and diseases
45. Insulin secretion from pancreatic β cells caused by L-arginine-derived nitrogen oxide
46. Optimized determination of angiotensin I-converting enzyme activity with hippuryl-L-histidyl-L-leucine as substrate
47. Human plasma and tirilazad mesylate protect stored human erythrocytes against the oxidative damage of gamma-irradiation
48. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries
49. Endothelial dysfunction in hypertension
50. Primary endothelial dysfunction: Atherosclerosis
51. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model: The hyperlipemic hyperglycemic hamster
52. Endothelial dysfunction: Update and clinical implications
53. Toxic effect of hyperglycaemia on rat aortic function and structure: Effect of L-arginine
54. Exposure of human erythrocytes to oxygen radicals causes loss of deformability, increased osmotic fragility, lipid peroxidation and protein degradation
55. Is measurement of endothelial dysfunction clinically useful?
56. L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts
57. Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbed carbohydrate metabolism in patients at risk for cardiovascular disease
58. Changes in endothelial actin cytoskeleton at leakage sites in the rat mesenteric microvasculature
59. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy
60. Vascular effects of L-arginine: Anything beyond a substrate for the NO-synthase?
61. Influence of fixation and morphometric techniques on capillary basement membrane thickening. Prevalence data in diabetes
62. An animal model to study erythrocyte senescence with a narrow time window of erythrocyte production: Alterations in osmotic fragility and deformability of erythrocytes during their life span
63. Red blood cell osmotic fragility in chronically hemodialyzed patients